Business Description
Stevanato Group SpA
ISIN : IT0005452658
Total Employee Number:
5,795Description
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.25 | |||||
Equity-to-Asset | 0.59 | |||||
Debt-to-Equity | 0.29 | |||||
Debt-to-EBITDA | 1.72 | |||||
Interest Coverage | 12.74 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 4.03 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 8.9 | |||||
3-Year EBITDA Growth Rate | 5.9 | |||||
3-Year EPS without NRI Growth Rate | 2.1 | |||||
3-Year Book Growth Rate | 17 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 17.15 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 8.93 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 44.87 | |||||
9-Day RSI | 51.07 | |||||
14-Day RSI | 53.49 | |||||
3-1 Month Momentum % | 14.27 | |||||
6-1 Month Momentum % | -9.77 | |||||
12-1 Month Momentum % | -27.43 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.63 | |||||
Quick Ratio | 1.11 | |||||
Cash Ratio | 0.2 | |||||
Days Inventory | 115.72 | |||||
Days Sales Outstanding | 80.26 | |||||
Days Payable | 99.68 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.32 | |||||
Dividend Payout Ratio | 0.1 | |||||
3-Year Dividend Growth Rate | 5.3 | |||||
Forward Dividend Yield % | 0.32 | |||||
5-Year Yield-on-Cost % | 0.32 | |||||
3-Year Average Share Buyback Ratio | -1 | |||||
Shareholder Yield % | -1.87 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 29.03 | |||||
Operating Margin % | 16.88 | |||||
Net Margin % | 11.76 | |||||
EBITDA Margin % | 21.49 | |||||
FCF Margin % | 15.92 | |||||
OCF Margin % | 21.75 | |||||
ROE % | 9.87 | |||||
ROA % | 5.72 | |||||
ROIC % | 9.55 | |||||
3-Year ROIIC % | 1.3 | |||||
ROC (Joel Greenblatt) % | 16.81 | |||||
ROCE % | 14.04 | |||||
Years of Profitability over Past 10-Year | 7 | |||||
Moat Score | 6 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 32.1 | |||||
Forward PE Ratio | 27.68 | |||||
PE Ratio without NRI | 30.61 | |||||
PEG Ratio | 3.33 | |||||
PS Ratio | 3.7 | |||||
PB Ratio | 2.95 | |||||
Price-to-Tangible-Book | 3.12 | |||||
Price-to-Free-Cash-Flow | 23.33 | |||||
Price-to-Operating-Cash-Flow | 17.08 | |||||
EV-to-EBIT | 22.97 | |||||
EV-to-Forward-EBIT | 16.46 | |||||
EV-to-EBITDA | 18.59 | |||||
EV-to-Forward-EBITDA | 16.82 | |||||
EV-to-Revenue | 4 | |||||
EV-to-Forward-Revenue | 4.4 | |||||
EV-to-FCF | 25.1 | |||||
Price-to-GF-Value | 0.71 | |||||
Price-to-Projected-FCF | 7.83 | |||||
Price-to-Graham-Number | 2.06 | |||||
Earnings Yield (Greenblatt) % | 4.35 | |||||
FCF Yield % | 4.28 | |||||
Forward Rate of Return (Yacktman) % | 1.81 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:STVN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Stevanato Group SpA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1,400.771 | ||
| EPS (TTM) ($) | 0.595 | ||
| Beta | 0.8328 | ||
| 3-Year Sharpe Ratio | -0.44 | ||
| 3-Year Sortino Ratio | -0.56 | ||
| Volatility % | 43.15 | ||
| 14-Day RSI | 53.49 | ||
| 14-Day ATR ($) | 0.85808 | ||
| 20-Day SMA ($) | 18.833 | ||
| 12-1 Month Momentum % | -27.43 | ||
| 52-Week Range ($) | 12.89 - 28 | ||
| Shares Outstanding (Mil) | 273 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Stevanato Group SpA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Stevanato Group SpA Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-06 08:30 | In 108 days | ||
| Third quarter earnings results for 2026 | 2026-11-06 06:30 | In 108 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-05 08:30 | In 15 days | ||
| Second quarter earnings results for 2026 | 2026-08-05 06:30 | In 15 days | ||
| EUR 0.054000 Cash Dividend | 2026-06-11 | 17.25 (-4.17%) | ||
| Jefferies Global Healthcare Conference in New York | 2026-06-04 09:55 | 18.53 (+0.60%) | ||
| William Blair 46th Annual Growth Stock Conference | 2026-06-02 14:40 | 18.87 (+1.51%) | ||
| General meeting for 2026 | 2026-05-26 10:00 | 18.01 (+0.95%) | ||
| Guidance call for 2026 | 2026-05-12 08:00 | 18.28 (-0.11%) | ||
| First quarter earnings conference call for 2026 | 2026-05-07 08:30 | 19.00 (+4.45%) |
Show
Entries
Stevanato Group SpA Frequently Asked Questions
What is Stevanato Group SpA(STVN)'s stock price today?
The current price of STVN is $19.10. The 52 week high of STVN is $28.00 and 52 week low is $12.89.
When is next earnings date of Stevanato Group SpA(STVN)?
The next earnings date of Stevanato Group SpA(STVN) is 2026-08-05 Est..
Does Stevanato Group SpA(STVN) pay dividends? If so, how much?
The Dividend Yield %  of Stevanato Group SpA(STVN) is 0.32% (As of Today), Highest Dividend Payout Ratio of Stevanato Group SpA(STVN) was 0.11. The lowest was 0.09. And the median was 0.1. The  Forward Dividend Yield % of Stevanato Group SpA(STVN) is 0.32%. For more information regarding to dividend, please check our Dividend Page.
Guru Commentaries on NYSE:STVN
No articles.
Press Release
Articles on Stevanato Group SpA
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers